ASLAN Pharmaceuticals Limited - American Depositary Shares (ASLN) SEC filings
ASLN SEC filings moved a median of -2.21% by the close. ASLN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ASLN overview →
24 measured ASLN SEC filing events.
Where these ASLN SEC filings landedvs 24 measured ASLN SEC filing reactions
| Middle 50% of ASLN SEC filing reactions | -8.22% to +2.53% |
|---|---|
| Median reaction (to close) | -2.21% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 ASLN SEC filing events with a measured close landed between -8.22% and +2.53%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 6-K ASLAN Pharmaceuticals For: Jul 17 | SEC filing · Form 6-K | -7.43% | +32.06% | |
| Form 6-K ASLAN Pharmaceuticals For: Jul 15 | SEC filing · Form 6-K | +14.51% | +5.34% | |
| Form EFFECT ASLAN Pharmaceuticals | SEC filing · Form EFFECT | -1.56% | -8.37% | |
| Form 6-K ASLAN Pharmaceuticals For: Jun 14 | SEC filing · Form 6-K | +0.25% | -9.75% | |
| Form F-3 ASLAN Pharmaceuticals | SEC filing · Form F-3 | -0.96% | -3.81% | |
| Form 6-K ASLAN Pharmaceuticals For: May 31 | SEC filing · Form 6-K | -4.54% | +2.23% | |
| Form 6-K ASLAN Pharmaceuticals For: May 09 | SEC filing · Form 6-K | +0.00% | -0.05% | |
| Form 6-K ASLAN Pharmaceuticals For: May 07 | SEC filing · Form 6-K | +6.63% | -2.11% | |
| Form 6-K ASLAN Pharmaceuticals For: Apr 22 | SEC filing · Form 6-K | -13.77% | -24.54% | |
| Form 6-K ASLAN Pharmaceuticals For: Apr 19 | SEC filing · Form 6-K | -13.77% | -24.54% | |
| Form 20-F ASLAN Pharmaceuticals For: Dec 31 | SEC filing · Form 20-F | -2.52% | -8.17% | |
| Form 6-K ASLAN Pharmaceuticals For: Apr 12 | SEC filing · Form 6-K | -2.52% | -8.17% | |
| Form S-8 ASLAN Pharmaceuticals | SEC filing · Form S-8 | -2.52% | -8.17% | |
| Form EFFECT ASLAN Pharmaceuticals | SEC filing · Form EFFECT | -1.16% | -1.56% | |
| Form D ASLAN Pharmaceuticals | SEC filing · Form D | +0.00% | +0.85% | |
| Form F-3 ASLAN Pharmaceuticals | SEC filing · Form F-3 | -0.92% | -2.31% | |
| Form 6-K ASLAN Pharmaceuticals For: Mar 13 | SEC filing · Form 6-K | +1.39% | +5.62% | |
| Form 6-K ASLAN Pharmaceuticals For: Mar 11 | SEC filing · Form 6-K | +9.98% | +160.38% | |
| Form 6-K ASLAN Pharmaceuticals For: Jan 24 | SEC filing · Form 6-K | -4.97% | -10.95% | |
| Form 6-K ASLAN Pharmaceuticals For: Jan 08 | SEC filing · Form 6-K | -2.75% | +10.40% | |
| Form 6-K ASLAN Pharmaceuticals For: Dec 23 | SEC filing · Form 6-K | -4.65% | -8.61% | |
| Form 6-K ASLAN Pharmaceuticals For: Dec 09 | SEC filing · Form 6-K | +2.75% | -0.98% | |
| Form 6-K ASLAN Pharmaceuticals For: Oct 27 | SEC filing · Form 6-K | — | -7.39% | |
| Form 6-K ASLAN Pharmaceuticals For: Oct 24 | SEC filing · Form 6-K | — | +3.45% |
Keep exploring
More ASLN: earnings → · analyst actions → · ASLN overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Medigus Ltd. - American Depositary Shares (MDGS) | 68 | -1.33% | 41% |
| AquaBounty Technologies, Inc. (AQB) | 67 | +0.01% | 51% |
| IMAGIN MEDICAL INC (IMEXF) | 67 | 0.00% | 25% |
| PRESSURE BIOSCIENCES (PBIO) | 67 | 0.00% | 27% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.